相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats
Irina Studneva et al.
CARDIOVASCULAR TOXICOLOGY (2019)
Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1
Monte S. Willis et al.
CIRCULATION-HEART FAILURE (2019)
Single nanomolar doxorubicin exposure triggers compensatory mitochondrial responses in H9c2 cardiomyoblasts
Luciana L. Ferreira et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
Xuerong Zhao et al.
PHARMACOLOGICAL RESEARCH (2019)
The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes
Alina Hanf et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes
Chen Ni et al.
JOURNAL OF PATHOLOGY (2019)
Effects of Calorie Restriction and Voluntary Exercise on Doxorubicin-Induced Cardiotoxicity
Stephanie E. Hall et al.
INTEGRATIVE CANCER THERAPIES (2019)
The natural compound 2,3,5,4′-tetrahydroxystilbene-2-O-β-D glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway
En-Yuan Lin et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice
Kirsty Foote et al.
AGING CELL (2018)
Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity
Yanhe Lue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Cardiolipin dynamics and binding to conserved residues in the mitochondrial ADP/ATP carrier
Anna L. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2018)
MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity
Xibo Jing et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Left Ventricular Mass Change After Anthracycline Chemotherapy
Jennifer H. Jordan et al.
CIRCULATION-HEART FAILURE (2018)
PGC-1: The Energetic Regulator in Cardiac Metabolism
Wencheng Di et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2018)
Effects of Resistance Exercise Training on Doxorubicin-Induced Cardiotoxicity
Keith Pfannenstiel et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium
Jiro Abe et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Programmed necrosis in heart disease: Molecular mechanisms and clinical implications
Hong Zhu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity
Fei Wang et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2G2019S-Parkinson's disease
Diana Luz Juarez-Flores et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Rita Zilinyi et al.
MOLECULES (2018)
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes
Teresa Cunha-Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway
Jian Yin et al.
TOXICOLOGY IN VITRO (2018)
HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy
Peihua Luo et al.
TOXICOLOGY LETTERS (2018)
Mitochondrial nicotinamide adenine dinucleotide reduced (NADH) oxidation links the tricarboxylic acid (TCA) cycle with methionine metabolism and nuclear DNA methylation
Oswaldo A. Lozoya et al.
PLOS BIOLOGY (2018)
Cardiovascular disease in survivors of childhood cancer
Neha Bansal et al.
CURRENT OPINION IN PEDIATRICS (2018)
Mitochondrial calcium transport and the redox nature of the calcium-induced membrane permeability transition
Anibal E. Vercesi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice
Zhi-Meng Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Breast Cancer Patients Receiving Anthracycline Chemotherapy and Trastuzumab Have Biventricular Dysfunction and Reduced Heart Mass
Brent A. McLean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association between mitochondrial DNA copy number and cardiovascular disease: Current evidence based on a systematic review and meta-analysis
Peng Yue et al.
PLOS ONE (2018)
Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling
I. Marques-Aleixo et al.
CARDIOVASCULAR TOXICOLOGY (2018)
The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT
Amy A. Kirkham et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT
A. A. Kirkham et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria
Andreas N. Kavazis et al.
MITOCHONDRION (2017)
Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis
Kaberi P. Das et al.
TOXICOLOGY (2017)
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
Andre Ferreira et al.
TOXICOLOGY (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy
Izabela Piotrowska et al.
PLOS ONE (2017)
UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
Lin An et al.
SCIENTIFIC REPORTS (2017)
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao et al.
SCIENTIFIC REPORTS (2017)
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
Ana R. Coelho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
High-Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure
Manuel Rosa-Garrido et al.
CIRCULATION (2017)
Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics
Junco Shibayama Warren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts
Susana F. Sampaio et al.
ARCHIVES OF TOXICOLOGY (2016)
Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
Jordan J. Bartlett et al.
BIOCHEMICAL JOURNAL (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Mitochondrial health, the epigenome and healthspan
Miguel A. Aon et al.
CLINICAL SCIENCE (2016)
Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
Laura K. Schnackenberg et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
1H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model
Qian-Yun Niu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function
Goncalo C. Pereira et al.
MITOCHONDRION (2016)
Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
Marcela Pizarro et al.
TOXICOLOGY (2016)
Doxorubicin Regulates Autophagy Signals via Accumulation of Cytosolic Ca2+ in Human Cardiac Progenitor Cells
Ji Hye Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Epigenetics in heart failure phenotypes
Alexander Berezin
BBA CLINICAL (2016)
Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity
Sae Rin Jean et al.
ACS CHEMICAL BIOLOGY (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts
Claudia M. Deus et al.
TOXICOLOGY (2015)
Autosis and autophagic cell death: the dark side of autophagy
Y. Liu et al.
CELL DEATH AND DIFFERENTIATION (2015)
A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
Yu Chen et al.
PLOS ONE (2015)
Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies
John M. Hollander et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
Xue Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts
Ana C. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
Shiwei Deng et al.
BMC CANCER (2014)
Turn up the power pharmacological activation of mitochondrial biogenesis in mouse models
J. C. Komen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Mitochondrial damage-associated molecular patterns and vascular function
Camilla Ferreira Wenceslau et al.
EUROPEAN HEART JOURNAL (2014)
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity
Debariya Dutta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle
Andreas N. Kavazis et al.
JOURNAL OF APPLIED PHYSIOLOGY (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
Rimpy Dhingra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts
Kendra K. S. Nordgren et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Role of Lysines in Cytochrome c-Cardiolipin Interaction
Federica Sinibaldi et al.
BIOCHEMISTRY (2013)
Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models
Sankarganesh Arunachalam et al.
FEBS LETTERS (2013)
Exercise Mitigates Cardiac Doxorubicin Accumulation and Preserves Function in the Rat
Brock T. Jensen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Salidroside Improves Doxorubicin-induced Cardiac Dysfunction by Suppression of Excessive Oxidative Stress and Cardiomyocyte Apoptosis
Xu-Lei Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
Run-Min Guo et al.
MOLECULAR MEDICINE REPORTS (2013)
Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor
Mayel Gharanei et al.
PLOS ONE (2013)
Humanin: a harbinger of mitochondrial-derived peptides?
Changhan Lee et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats
Zhih-Cherng Chen et al.
PPAR RESEARCH (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Atsushi Hoshino et al.
NATURE COMMUNICATIONS (2013)
Mitochondrial regulation of epigenetics and its role in human diseases
Sheroy Minocherhomji et al.
EPIGENETICS (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific
Goncalo C. Pereira et al.
PLOS ONE (2012)
Mitochondrial bioenergetics and drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA single nucleotide polymorphisms
Claudia V. Pereira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Adriamycin inhibits adipogenesis through the modulation of PPARγ and restoration of adriamycin-mediated inhibition of adipogenesis by PPARγ over-expression
Sankarganesh Arunachalam et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
Transcriptional integration of mitochondrial biogenesis
Richard C. Scarpulla et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Richard C. Scarpulla
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mitochondrial turnover in the heart
Roberta A. Gottlieb et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance
Andrew Skildum et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis
Andrea Rasola et al.
CELL CALCIUM (2011)
Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats
Antonio Ascensao et al.
CLINICAL SCIENCE (2011)
Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics
Xavier Marechal et al.
CLINICAL SCIENCE (2011)
Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium
David Montaigne et al.
MITOCHONDRION (2011)
Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application
Guangguo Tan et al.
PLOS ONE (2011)
Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA
Soochan Bae et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Satoru Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Energetics, epigenetics, mitochondrial genetics
Douglas C. Wallace et al.
MITOCHONDRION (2010)
Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
Rui A. Carvalho et al.
TOXICOLOGY (2010)
Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q
Karunakaran Chandran et al.
BIOPHYSICAL JOURNAL (2009)
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
Vilma A. Sardao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Cytochrome c/cardiolipin relations in mitochondria: a kiss of death
Valerian E. Kagan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling
N. Ashley et al.
ONCOGENE (2009)
Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1α:: implications for metabolic disease
Deborah M. Muoio et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Early and late arrhythmogenic effects of doxorubicin
Saadettin Kilickap et al.
SOUTHERN MEDICAL JOURNAL (2007)
Persistent alterations to the gene expression profile of the heart subsequent to chronic doxorubicin treatment
Jessica M. Berthiaume et al.
CARDIOVASCULAR TOXICOLOGY (2007)
New iron chelators in anthracycline-induced cardiotoxicity
Helena Kaiserova et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats- Relevance for mitochondrial. dysfunction
PJ Oliveira et al.
TOXICOLOGY (2006)
Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria
R Kametani et al.
CIRCULATION JOURNAL (2006)
Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo
Satoru Kobayashi et al.
FASEB JOURNAL (2006)
Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity
AJ Chicco et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study
JJ Doyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis
A Ascensao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply
M Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction
JM Berthiaume et al.
CARDIOVASCULAR TOXICOLOGY (2005)
Nuclear receptor signaling and cardiac energetics
JM Huss et al.
CIRCULATION RESEARCH (2004)
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity
PJ Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases
B Faustin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin
BB Hasinoff et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy
DL Santos et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Antioxidant nutrients and adriamycin toxicity
JL Quiles et al.
TOXICOLOGY (2002)
The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase
T Cocco et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2002)
Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
Multiple interference of anthracyclines with mitochondrial creatine kinases: Preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity
M Tokarska-Schlattner et al.
MOLECULAR PHARMACOLOGY (2002)
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs
R Danesi et al.
CLINICAL PHARMACOKINETICS (2002)
Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers
MA Parker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats
S Zhou et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Doxorubicin-induced persistent oxidative stress to cardiac myocytes
SY Zhou et al.
TOXICOLOGY LETTERS (2001)
What do mitochondrial diseases teach us about normal mitochondrial functions... that we already knew: threshold expression of mitochondrial defects
JP Mazat et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2001)
分享论文
